IDH1 and glioblastoma: We searched for differential features of glutaminolysis related to GBM aggressiveness and malignant progression of low-grade astrocytomas with IDH1 mutation, which may help to better characterize the metabolic features associated with GBM aggressiveness and to tumor malignant progression.